| Attribute |
Value |
| 52 Week Change |
-0.62658226 |
| Address1 |
3,480 Peachtree Road NE |
| Address2 |
Second Floor, Suite 103 |
| All Time High |
45,292.5 |
| All Time Low |
0.84 |
| Ask |
1.47 |
| Ask Size |
2 |
| Average Daily Volume10 Day |
555,090 |
| Average Daily Volume3 Month |
153,339 |
| Average Volume |
153,339 |
| Average Volume10Days |
555,090 |
| Beta |
0.142 |
| Bid |
0.8424 |
| Bid Size |
2 |
| Book Value |
0.574 |
| City |
Atlanta |
| Compensation As Of Epoch Date |
1,767,139,200 |
| Country |
United States |
| Crypto Tradeable |
0 |
| Currency |
USD |
| Current Price |
1.16 |
| Current Ratio |
1.992 |
| Custom Price Alert Confidence |
HIGH |
| Date Short Interest |
1,782,777,600 |
| Day High |
1.2033 |
| Day Low |
1.1201 |
| Display Name |
Alzamend Neuro |
| Earnings Timestamp End |
1,754,164,800 |
| Earnings Timestamp Start |
1,753,732,800 |
| Ebitda |
-6,939,160 |
| Ebitda Margins |
0.0 |
| Enterprise To Ebitda |
-0.245 |
| Enterprise Value |
1,700,360 |
| Eps Current Year |
-2.58 |
| Eps Forward |
-2.6 |
| Eps Trailing Twelve Months |
-3.67 |
| Esg Populated |
0 |
| Exchange |
NCM |
| Exchange Data Delayed By |
0 |
| Exchange Timezone Name |
America/New_York |
| Exchange Timezone Short Name |
EDT |
| Fifty Day Average |
1.1491 |
| Fifty Day Average Change |
0.010900021 |
| Fifty Day Average Change Percent |
0.009485703 |
| Fifty Two Week Change Percent |
-62.658226 |
| Fifty Two Week High |
3.6 |
| Fifty Two Week High Change |
-2.44 |
| Fifty Two Week High Change Percent |
-0.6777778 |
| Fifty Two Week Low |
0.84 |
| Fifty Two Week Low Change |
0.32 |
| Fifty Two Week Low Change Percent |
0.3809524 |
| Fifty Two Week Range |
0.84 - 3.6 |
| Financial Currency |
USD |
| First Trade Date Milliseconds |
1,623,763,800,000 |
| Float Shares |
3,792,870 |
| Forward Eps |
-2.6 |
| Forward P E |
-0.44615385 |
| Free Cashflow |
-3,615,899 |
| Full Exchange Name |
NasdaqCM |
| Full Time Employees |
4 |
| Gmt Off Set Milliseconds |
-14,400,000 |
| Gross Margins |
0.0 |
| Has Pre Post Market Data |
1 |
| Held Percent Insiders |
0.0053 |
| Held Percent Institutions |
0.030350002 |
| Implied Shares Outstanding |
3,804,741 |
| Industry |
Biotechnology |
| Industry Disp |
Biotechnology |
| Industry Key |
biotechnology |
| Ipo Expected Date |
2,021-06-15 |
| Is Earnings Date Estimate |
1 |
| Language |
en-US |
| Last Fiscal Year End |
1,745,971,200 |
| Last Split Date |
1,747,008,000 |
| Last Split Factor |
1:9 |
| Long Business Summary |
Alzamend Neuro, Inc., a clinical-stage biopharmaceutical company, focuses on developing various products for the treatment of neurodegenerative and psychiatric disorders. Its pipeline includes AL001, which delivers a therapeutic combination of lithium, proline, and salicylate for the treatment of Alzheimer's, bi-polar disorder, post-traumatic stress disorder, major depressive disorder, other neurodegenerative diseases, and psychiatric disorders; and ALZN002, which uses a method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine to restore the ability of a patient's immunological system to combat Alzheimer's disease. Alzamend Neuro, Inc. was incorporated in 2016 and is headquartered in Atlanta, Georgia. |
| Long Name |
Alzamend Neuro, Inc. |
| Market |
us_market |
| Market Cap |
4,413,499 |
| Market State |
PRE |
| Max Age |
86,400 |
| Message Board Id |
finmb_367712111 |
| Most Recent Quarter |
1,769,817,600 |
| Net Income To Common |
-7,544,730 |
| Next Fiscal Year End |
1,777,507,200 |
| Non Diluted Market Cap |
4,489,594 |
| Number Of Analyst Opinions |
1 |
| Open |
1.1499 |
| Operating Cashflow |
-5,959,224 |
| Operating Margins |
0.0 |
| Payout Ratio |
0.0 |
| Phone |
844 722 6333 |
| Previous Close |
1.18 |
| Price Eps Current Year |
-0.4496124 |
| Price Hint |
4 |
| Price To Book |
2.020906 |
| Profit Margins |
0.0 |
| Quick Ratio |
1.461 |
| Quote Source Name |
Nasdaq Real Time Price |
| Quote Type |
EQUITY |
| Recommendation Key |
none |
| Region |
US |
| Regular Market Change |
-0.02 |
| Regular Market Change Percent |
-1.69491 |
| Regular Market Day High |
1.2033 |
| Regular Market Day Low |
1.1201 |
| Regular Market Day Range |
1.1201 - 1.2033 |
| Regular Market Open |
1.1499 |
| Regular Market Previous Close |
1.18 |
| Regular Market Price |
1.16 |
| Regular Market Time |
1,783,972,801 |
| Regular Market Volume |
46,364 |
| Return On Assets |
-1.07011 |
| Return On Equity |
-2.49965 |
| Sand P52 Week Change |
0.20847368 |
| Sector |
Healthcare |
| Sector Disp |
Healthcare |
| Sector Key |
healthcare |
| Shares Outstanding |
3,804,741 |
| Shares Percent Shares Out |
0.0414 |
| Shares Short |
157,517 |
| Shares Short Previous Month Date |
1,780,012,800 |
| Shares Short Prior Month |
149,007 |
| Short Name |
Alzamend Neuro, Inc. |
| Short Percent Of Float |
0.0416 |
| Short Ratio |
0.84 |
| Source Interval |
15 |
| State |
GA |
| Symbol |
ALZN |
| Target High Price |
25.0 |
| Target Low Price |
25.0 |
| Target Mean Price |
25.0 |
| Target Median Price |
25.0 |
| Total Cash |
2,713,139 |
| Total Cash Per Share |
0.713 |
| Total Debt |
0 |
| Tradeable |
0 |
| Trailing Annual Dividend Rate |
0.0 |
| Trailing Annual Dividend Yield |
0.0 |
| Trailing Eps |
-3.67 |
| Trailing Peg Ratio |
None |
| Triggerable |
1 |
| Two Hundred Day Average |
1.790155 |
| Two Hundred Day Average Change |
-0.6301551 |
| Two Hundred Day Average Change Percent |
-0.35201144 |
| Type Disp |
Equity |
| Volume |
46,364 |
| Website |
https://www.alzamend.com |
| Zip |
30,326 |